Most importantly, deciphering the molecular mechanisms for the PCAT3/PCAT9-miR-203-SNAI2 axis linked to prostate cancer initiation and progression is of great importance for developing new diagnostic and therapeutic method. This evidence concerns the gene PCGEM1 and prostate cancer.